Home › Scleroderma › South Carolina › Charleston
Scleroderma clinical trials in Charleston, SC
4 studies for Scleroderma are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Medical University of South Carolina (MUSC), Charleston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Charleston, Charleston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, Charleston
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Chicago, IL10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Durham, NC7 studies
- Los Angeles, CA7 studies
- New Orleans, LA6 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
Other studies in Charleston
- Depression19 studies
- Stroke18 studies
- Heart Failure18 studies
- Post-Traumatic Stress Disorder16 studies
- Non-Small Cell Lung Cancer16 studies
- Prostate Cancer15 studies
- Cardiovascular Disease15 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Cancer (all types)14 studies
- Parkinson's Disease13 studies
- Interstitial Lung Diseases13 studies
- Breast Cancer12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.